CN1343728A - Natural plant polyose - Google Patents

Natural plant polyose Download PDF

Info

Publication number
CN1343728A
CN1343728A CN 00124538 CN00124538A CN1343728A CN 1343728 A CN1343728 A CN 1343728A CN 00124538 CN00124538 CN 00124538 CN 00124538 A CN00124538 A CN 00124538A CN 1343728 A CN1343728 A CN 1343728A
Authority
CN
China
Prior art keywords
natural plant
licorice
plant polyose
raw material
matrimony vine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 00124538
Other languages
Chinese (zh)
Other versions
CN1138787C (en
Inventor
宋飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Pharmaceutical Biotechnology Co., Ltd.
Original Assignee
BEITE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd TIANJIN CITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEITE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd TIANJIN CITY filed Critical BEITE SCIENCE AND TECHNOLOGY DEVELOPMENT Co Ltd TIANJIN CITY
Priority to CNB001245384A priority Critical patent/CN1138787C/en
Publication of CN1343728A publication Critical patent/CN1343728A/en
Application granted granted Critical
Publication of CN1138787C publication Critical patent/CN1138787C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A natural phytopolyose is prepared from the coarse wolfberry polyose extracted from wolfberry fruit and the coarse liquorice polyose extracted from liquorice root through mixing in ratio of 1:9 and loading the mixture in capsules. It can enhance the immunity of body fluid and cells and suppress the tumor cells and viruses, so playing the role of suppressing and deactivating viruses.

Description

Natural plant polyose
The invention belongs to the extract of the Chinese medicine that derives from vegetable material, particularly a kind of Radix Glycyrrhizae, the effective part extract of matrimony vine, relevant mediator's body immunity function presses down tumor killing cell, suppresses the natural plant polyose of AIDS.
At present, tumour is common frequently-occurring disease, and it does not still have specifics in western medicine at home and abroad, and the drug price costliness, makes most of patients give birth to fear; In recent years, China's Chinese traditional treatment tumor research is very active, has all obtained certain progress from the basic theory to the clinical treatment.Report that from all parts of the country curative effect differs, benevolence intelligence is respectively seen.How improving clinical efficacy for this reason, visit and get the treatment rule, is the task of top priority.
The objective of the invention is, provide a kind of mediator's body immunity function to suppress " natural plant polyose " of tumour and AIDS
The present invention is achieved in that treatment tumour, mediator's body immunity function, and the natural plant polyose of AIDS resisting is prepared as follows by the efficient part of matrimony vine, Radix Glycyrrhizae:
One, (1) raw material is handled and the extract preparation
1.1, soak the removal pigment through pure backwash with Chinese wolfberry fruit flushing with clean water impurity elimination.
Added water boil 7 hours 1.2 will remove the wolfberry fruit of pigment, cool slightly, filter out impurities, obtain clear liquid.
1.3 concentrate clear liquid, use alcohol precipitation.
1.4 it is centrifugal, obtain settling.
1.5 the matrimony vine Crude polysaccharides is dried, grinds, sieves, promptly obtained to settling.
(2) licorice raw material is handled and the extract preparation.
2.1 licorice, stem clear water rinsing impurity elimination with well cutting.
2.2 the raw material after the impurity elimination is added water, and boiling water boiled 7~8 hours, and is cool slightly, filters out impurities, and obtains clear liquid.
2.3 through activated carbon decolorizing.
2.4 destainer concentrates, and uses alcohol precipitation.
2.5 the centrifugal precipitating thing that obtains.
2.6 the Radix Glycyrrhizae Crude polysaccharides is dried, grinds, sieves, promptly obtained to the precipitating thing.
Two, capsule contents proportioning and packing
Get lycium barbarum polysaccharide 10%, licorice polysaccharide 90% mixes, and incapsulates, through physical method sterilization, pressing plate, packing.
Three, natural plant polyose physics and chemistry characteristics and characteristic
1. look khaki.
2. it is little sweet to distinguish the flavor of.
3. soluble in water, the tool viscosity higher.
4. good to non-primary tumor effect.
Prove that through a large amount of scientific experiments this product can not only activating macrophage, the TB lymphocyte, thus strengthen the dual-use function of humoral immunization and cellular immunization.Have and suppress the effect of tumour cell telomere and, make genome (DNA or RNA) from suppressing this capsule of Analysis on Mechanism the restraining effect of the reversed transcriptive enzyme of multiple virus, can't normal replication, thus play inhibition or directly deactivation to virus.
Fig. 1 is the natural plant polyose process flow sheet
This product is confirmed non-toxic substance through the toxicological assessment examining report.(seeing Appendix 1).
This product is confirmed stay in grade through functional component, the stability test of healthcare products.(seeing Appendix 2).
This product has restraining effect and directly deactivation through the antagonism virus research, and research has obvious promoter action that immunologic enhancement is arranged to macrophage phagocytic function, tumor-inhibiting action is tested the pyknosis of visible large stretch of degeneration necrosis cell and the property made distribution.(seeing Appendix 3).
This product shows through antagonism AIDS drug testing report: virus replication is had certain restraining effect, is 36.2% to viral inhibiting rate.(seeing Appendix 4)

Claims (2)

1, a kind of natural plant polyose is characterized in that: it is the product that the efficient part by matrimony vine, Radix Glycyrrhizae prepares by the method for being prepared as follows; Its preparation method is:
(1) the matrimony vine raw material is handled and the extract preparation
1.1, soak the removal pigment through pure backwash with Chinese wolfberry fruit flushing with clean water impurity elimination;
Added water boil 7 hours 1.2 will remove the wolfberry fruit of pigment, cool slightly, filter out impurities, obtain clear liquid;
1.3 concentrate clear liquid, use alcohol precipitation;
1.4 it is centrifugal, obtain settling;
1.5 the matrimony vine Crude polysaccharides is dried, grinds, sieves, promptly obtained to settling;
(2) licorice raw material is handled and the extract preparation;
2.1 licorice, stem clear water rinsing impurity elimination with well cutting;
2.2 the raw material after the impurity elimination is added water, and boiling water boiled 7~8 hours, and is cool slightly, filters out impurities, and obtains clear liquid;
2.3 through activated carbon decolorizing;
2.4 destainer concentrates, and uses alcohol precipitation;
2.5 the centrifugal precipitating thing that obtains;
2.6 the Radix Glycyrrhizae Crude polysaccharides is dried, grinds, sieves, promptly obtained to the precipitating thing; The inclusion proportioning: get lycium barbarum polysaccharide 10%, licorice polysaccharide 90% mixes.
2, natural plant polyose according to claim 1 is characterized in that: with proportioning: lycium barbarum polysaccharide 10%, licorice polysaccharide 90% mixes natural plant polyose, incapsulates, through physical method sterilization, pressing plate, packing.
CNB001245384A 2000-09-20 2000-09-20 Natural plant polyose Expired - Fee Related CN1138787C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001245384A CN1138787C (en) 2000-09-20 2000-09-20 Natural plant polyose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001245384A CN1138787C (en) 2000-09-20 2000-09-20 Natural plant polyose

Publications (2)

Publication Number Publication Date
CN1343728A true CN1343728A (en) 2002-04-10
CN1138787C CN1138787C (en) 2004-02-18

Family

ID=4590487

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001245384A Expired - Fee Related CN1138787C (en) 2000-09-20 2000-09-20 Natural plant polyose

Country Status (1)

Country Link
CN (1) CN1138787C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012130122A1 (en) * 2011-04-01 2012-10-04 桂林商源植物制品有限公司 Pharmaceutical composition for controlling blood sugar, blood lipid and body weight
CN105876303A (en) * 2015-01-26 2016-08-24 济南金植医药技术有限公司 Health-preserving Chinese wolfberry fruit compound and preparation method thereof
CN111777695A (en) * 2019-04-04 2020-10-16 中国科学院上海药物研究所 Lycium ruthenicum polysaccharide LRP3-S1, and preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102511716A (en) * 2011-12-29 2012-06-27 天津大学 Glycyrrhiza polysaccharide granules and preparation method thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012130122A1 (en) * 2011-04-01 2012-10-04 桂林商源植物制品有限公司 Pharmaceutical composition for controlling blood sugar, blood lipid and body weight
GB2503628A (en) * 2011-04-01 2014-01-01 Sourcing Biz Guilin Inc Pharmaceutical compostion for controlling blood sugar, blood lipid and body weight
CN103608024A (en) * 2011-04-01 2014-02-26 桂林商源植物制品有限公司 Pharmaceutical composition for controlling blood sugar, blood lipid and body weight
CN103608024B (en) * 2011-04-01 2016-04-13 桂林商源植物制品有限公司 Control the pharmaceutical composition of blood glucose, blood fat and body weight
US10894070B2 (en) 2011-04-01 2021-01-19 James Zhou Drug compound for the control of blood glucose, blood lipids and weight
CN105876303A (en) * 2015-01-26 2016-08-24 济南金植医药技术有限公司 Health-preserving Chinese wolfberry fruit compound and preparation method thereof
CN111777695A (en) * 2019-04-04 2020-10-16 中国科学院上海药物研究所 Lycium ruthenicum polysaccharide LRP3-S1, and preparation method and application thereof
CN111777695B (en) * 2019-04-04 2021-11-26 中国科学院上海药物研究所 Lycium ruthenicum polysaccharide LRP3-S1, and preparation method and application thereof

Also Published As

Publication number Publication date
CN1138787C (en) 2004-02-18

Similar Documents

Publication Publication Date Title
CN1824761A (en) Salamander health care wine and its preparation method
CN111057163A (en) Preparation method and application of inonotus obliquus extract
CN102835508B (en) Lyceum chinense-green tea beverage
CN106279462A (en) The extracting method of astragalus polysaccharides and the preparation method of astragalus polysaccharides oral liquid for animals
CN1343728A (en) Natural plant polyose
CN105462793B (en) A kind of healthy medicated wine its preparation method
CA1324084C (en) Method of extracting a physiological active substance from the husks of pine nuts and anti-contagion medicine made of said extract as principal raw material
CN1343729A (en) Liquorice polyose
KR101283323B1 (en) Production method of ginseng steamed red concentrated solution
CN102475764A (en) Preparation method of Shenkang injection
CN101463052B (en) Preparation of longan peel oligosaccharides
CN105746987A (en) Asthenopia-relieving chewable tablet and preparation method thereof
CN1190153C (en) Oral health care products using extreated mung bean juice as mother liquor and preparation method thereof
CN110664876B (en) Extraction method of polyphenol component in Chinese date fruit drop
CN102660444A (en) Healthcare wine and preparation method thereof
CN1241500C (en) Functional health-care drink and its preparing process
CN112690451A (en) Application of ginseng alcohol extract in sleep-promoting health-care product or food
CN105146662A (en) Rubus delavayi plant compound beverage and preparing method thereof
CN109170894A (en) A kind of cape jasmine health care product and preparation method thereof for reducing blood sugar and blood lipid
CN1701722A (en) Bitter bamboo beverage and preparation method thereof
CN113214070B (en) Preparation method of aurantio-obtusin and application of aurantio-obtusin in health-care product for relaxing bowels
CN107373259A (en) One kind relaxes bowel Chinese herbal health-caring beverage and preparation method thereof
CN103735593A (en) Preparation method for safflower injection liquid
CN107348051A (en) A kind of calming liver and clearing heat blood pressure reducing health-care tea and preparation method thereof
CN107467295A (en) One kind preventing and treating sphagitis Chinese herbal medicine health care cold tea and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TIANJIN PHARMACEUTICAL BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: BEITE SCIENCE AND TECHNOLOGY DEVELOPMENT CO LTD, TIANJIN CITY

Effective date: 20051125

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20051125

Address after: 300192 No. 12, West research road, Tianjin, Nankai District 353

Patentee after: Tianjin Pharmaceutical Biotechnology Co., Ltd.

Address before: 300381 Tianjin City, Nankai District Lexi Ning 12 floor door

Patentee before: Beite Science and Technology Development Co., Ltd., Tianjin City

PC01 Cancellation of the registration of the contract for pledge of patent right

Date of registration: 20070920

Pledge (preservation): Pledge

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040218

Termination date: 20160920